RBR-3vxgjsj
Prospective Evaluation of the Use of PET-CT in Hepatocarcinoma
Prospective Evaluation of the Use of PET-CT with 18 F -PSMA in Hepatocarcinoma: Comparison With Conventional Morphological Methods and Impact on Management Change
Fundação Antônio Prudente - AC Camargo Cancer Center·Registro Brasileiro De Ensaios ClinicosRecruiting
Study focus
- Disease/Condition
- Hepatocellular carcinoma
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Fundação Antônio Prudente - AC Camargo Cancer Center
- Location
- Brazil
Timeline & enrollment
- Phase
- N/A
- Start date
- Jan 01, 2023
- End date
- N/A
ICD-10 classifications
Malignant neoplasm: HepatoblastomaMalignant neoplasm: Liver cell carcinomaMalignant neoplasm: Other specified carcinomas of liverMalignant neoplasm: Liver, unspecifiedMalignant neoplasm: Hepatic flexure
Data source
- Registry
- Registro Brasileiro De Ensaios Clinicos
- Trial ID
- RBR-3vxgjsj
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for RBR-3vxgjsj through Pure Global AI's free database. This phase not specified trial is sponsored by Fundação Antônio Prudente - AC Camargo Cancer Center and is currently Recruiting. The study focuses on Hepatocellular carcinoma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Registro Brasileiro De Ensaios Clinicos data, helping medical device and pharmaceutical companies navigate clinical research efficiently.